Australia's most trusted
source of pharma news
Monday, 21 April 2025
Posted 17 April 2025 PM
US President Donald Trump is looking to eliminate the so-called "pill penalty" in a win for industry but analysts are branding it a "bread crumb concession" ahead of tariffs.
Trump signed an Executive Order (EO) this week containing a long list of proposed changes for pharma with the most pleasing, a shake-up to the Inflation Reduction Act that gives small molecule drugs just nine years before Medicare price negotiations can commence, compared to 13 years for biologics.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.